The catalytic activity of the ErbB-2 receptor tyrosine kinase is essential for embryonic development

被引:47
|
作者
Chan, R
Hardy, WR
Laing, MA
Hardy, SE
Muller, WJ
机构
[1] McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada
[2] McMaster Univ, Dept Biochem, Hamilton, ON L8S 4K1, Canada
[3] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4K1, Canada
关键词
D O I
10.1128/MCB.22.4.1073-1078.2002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of the epidermal growth factor receptor (EGFR) family is thought to play a critical role in both embryogenesis and oncogenesis. The diverse biological activities of the EGFR family are achieved through various ligand-receptor and receptor-receptor interactions. One receptor that has been found to play a central role in this signaling network is ErbB-2/Neu, and it is considered the preferred heterodimerization partner for other members of the EGFR family. To assess the importance of the catalytic activity of ErbB-2 in embryonic development, we have generated mice expressing a kinase-dead erbB-2 cDNA under the transcriptional control of the endogenous promoter. Here, we show that mice homozygous for the kinase-dead erbB-2 allele die at midgestation and display the same spectrum of embryonic defects seen in erbB-2 knockout mutants. These observations suggest that the catalytic activity of ErbB-2 is essential for normal embryonic development.
引用
收藏
页码:1073 / 1078
页数:6
相关论文
共 50 条
  • [31] ErbB receptor tyrosine kinase inhibitors as therapeutic agents
    Anderson, NG
    Ahmad, T
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2002, 7 : D1926 - D1940
  • [32] Progesterone receptor and ErbB-2 crosstalk in breast cancer
    Beguelin, Wendy
    Flaque, Maria C. Diaz
    Cayrol, Florencia
    Proietti, Cecilia J.
    Rivas, Martin A.
    Tkach, Mercedes
    Charreau, Eduardo H.
    Schillaci, Roxana
    Elizalde, Patricia V.
    CANCER RESEARCH, 2010, 70
  • [33] Discovery and biological evaluation of potent dual ErbB-2/EGFR tyrosine kinase inhibitors: 6-thiazolylquinazolines
    Gaul, MD
    Guo, Y
    Affleck, K
    Cockerill, GS
    Gilmer, TM
    Griffin, RJ
    Guntrip, S
    Keith, BR
    Knight, WB
    Mullin, RJ
    Murray, DM
    Rusnak, DW
    Smith, K
    Tadepalli, S
    Wood, ER
    Lackey, K
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (04) : 637 - 640
  • [34] Characterization of human breast cancer cells with acquired resistance to the EGFR/ErbB-2 tyrosine kinase inhibitor lapatinib
    De Luca, Antonella
    Faraso, Stefania
    D'Alessio, Amelia
    Gallo, Marianna
    Lamura, Luana
    Maiello, Monica R.
    Normanno, Nicola
    CANCER RESEARCH, 2011, 71
  • [35] Discovery and profile of GW572016, a dual reversible EGFR/ErbB-2 tyrosine kinase inhibitor.
    Mullin, RJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U2 - U2
  • [36] Epiregulin binds to epidermal growth factor receptor and ErbB-4, and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3, and ErbB-4
    Komurasaki, T
    Toyoda, H
    Uchida, D
    Morimoto, S
    FASEB JOURNAL, 1997, 11 (09): : A1048 - A1048
  • [37] Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4
    Komurasaki, T
    Toyoda, H
    Uchida, D
    Morimoto, S
    ONCOGENE, 1997, 15 (23) : 2841 - 2848
  • [38] A phosphoproteomic analysis of the ErbB2 receptor tyrosine kinase signaling pathways
    Mukherji, Mridul
    Brill, Laurence M.
    Ficarro, Scott B.
    Hampton, Garret M.
    Schultz, Peter G.
    BIOCHEMISTRY, 2006, 45 (51) : 15529 - 15540
  • [39] THE C-ERBB-2 GENE ENCODES A RECEPTOR-LIKE PROTEIN WITH TYROSINE KINASE-ACTIVITY
    TOYOSHIMA, K
    SEMBA, K
    AKIYAMA, T
    IKAWA, S
    YAMAMOTO, T
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1986, 51 : 977 - 982
  • [40] Tyrosine kinase signalling in breast cancer - ErbB family receptor tyrosine kinases
    Stern, DF
    BREAST CANCER RESEARCH, 2000, 2 (03) : 176 - 183